Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MedAdvisor Limited ( (AU:AHE) ) has provided an update.
Adheris Health Limited has lodged an application with the ASX for the quotation of 169,640 ordinary fully paid shares under its existing ticker AHE, with an issue date of 10 February 2026. The relatively small issuance, arising from the exercise or conversion of existing options or other convertible securities, suggests a routine capital management move rather than a major strategic shift, incrementally increasing the company’s free float and potentially enhancing liquidity for shareholders.
The most recent analyst rating on (AU:AHE) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:AHE Stock Forecast page.
More about MedAdvisor Limited
Adheris Health Limited, listed on the ASX under the code AHE, operates within the healthcare sector. The company’s focus appears to be on health-related services or solutions, although the specific products, services, and market focus are not detailed in the filing, which is a standard securities quotation application.
Average Trading Volume: 1,229,686
Technical Sentiment Signal: Sell
Current Market Cap: A$12.74M
See more data about AHE stock on TipRanks’ Stock Analysis page.